Dataset
Dataset: covid-19_results_mar_dec_2020.zip, 1.22 GB
Access Condition: Open access

Documentation: efficacy_of_fda_approved_hiv_drugs_on_sars-cov-2.txt, 720 bytes
Access Condition: Open access
Description:
Methodology description (English)

Please login to the repository to save this object to your list.
Cite this document

Tomić, D. (2021). Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein [Data set]. https://urn.nsk.hr/urn:nbn:hr:241:733364.

Tomić, Draško. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. Institut Ruđer Bošković, 2021. 06 Mar 2024. https://urn.nsk.hr/urn:nbn:hr:241:733364.

Tomić, Draško. 2021. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. Institut Ruđer Bošković. https://urn.nsk.hr/urn:nbn:hr:241:733364.

Tomić, D. 2021. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. Institut Ruđer Bošković. [Online]. [Accessed 06 March 2024]. Available from: https://urn.nsk.hr/urn:nbn:hr:241:733364.

Tomić D. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. [Internet]. Institut Ruđer Bošković: , HR; 2021, [cited 2024 March 06] Available from: https://urn.nsk.hr/urn:nbn:hr:241:733364.

D. Tomić, Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein, Institut Ruđer Bošković, 2021. Accessed on: Mar 06, 2024. Available: https://urn.nsk.hr/urn:nbn:hr:241:733364.